Literature DB >> 32134398

Ventromedial hypothalamic nucleus neuronal subset regulates blood glucose independently of insulin.

Jonathan N Flak1, Paulette B Goforth2, James Dell'Orco1, Paul V Sabatini1, Chien Li3, Nadejda Bozadjieva4, Matthew Sorensen5, Alec Valenta5, Alan Rupp1, Alison H Affinati1, Corentin Cras-Méneur1, Ahsan Ansari1, Jamie Sacksner1, Nandan Kodur1, Darleen A Sandoval4, Robert T Kennedy5, David P Olson6, Martin G Myers1.   

Abstract

To identify neurons that specifically increase blood glucose from among the diversely functioning cell types in the ventromedial hypothalamic nucleus (VMN), we studied the cholecystokinin receptor B-expressing (CCKBR-expressing) VMN targets of glucose-elevating parabrachial nucleus neurons. Activation of these VMNCCKBR neurons increased blood glucose. Furthermore, although silencing the broader VMN decreased energy expenditure and promoted weight gain without altering blood glucose levels, silencing VMNCCKBR neurons decreased hIepatic glucose production, insulin-independently decreasing blood glucose without altering energy balance. Silencing VMNCCKBR neurons also impaired the counterregulatory response to insulin-induced hypoglycemia and glucoprivation and replicated hypoglycemia-associated autonomic failure. Hence, VMNCCKBR cells represent a specialized subset of VMN cells that function to elevate glucose. These cells not only mediate the allostatic response to hypoglycemia but also modulate the homeostatic setpoint for blood glucose in an insulin-independent manner, consistent with a role for the brain in the insulin-independent control of glucose homeostasis.

Entities:  

Keywords:  Endocrinology; Glucose metabolism; Metabolism; Neuroendocrine regulation

Mesh:

Substances:

Year:  2020        PMID: 32134398      PMCID: PMC7260001          DOI: 10.1172/JCI134135

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   19.456


  42 in total

Review 1.  Cooperation between brain and islet in glucose homeostasis and diabetes.

Authors:  Michael W Schwartz; Randy J Seeley; Matthias H Tschöp; Stephen C Woods; Gregory J Morton; Martin G Myers; David D'Alessio
Journal:  Nature       Date:  2013-11-07       Impact factor: 49.962

2.  Insulin resistance and metabolic derangements in obese mice are ameliorated by a novel peroxisome proliferator-activated receptor γ-sparing thiazolidinedione.

Authors:  Zhouji Chen; Patrick A Vigueira; Kari T Chambers; Angela M Hall; Mayurranjan S Mitra; Nathan Qi; William G McDonald; Jerry R Colca; Rolf F Kletzien; Brian N Finck
Journal:  J Biol Chem       Date:  2012-05-23       Impact factor: 5.157

3.  Fiji: an open-source platform for biological-image analysis.

Authors:  Johannes Schindelin; Ignacio Arganda-Carreras; Erwin Frise; Verena Kaynig; Mark Longair; Tobias Pietzsch; Stephan Preibisch; Curtis Rueden; Stephan Saalfeld; Benjamin Schmid; Jean-Yves Tinevez; Daniel James White; Volker Hartenstein; Kevin Eliceiri; Pavel Tomancak; Albert Cardona
Journal:  Nat Methods       Date:  2012-06-28       Impact factor: 28.547

Review 4.  Neuronal glucosensing: what do we know after 50 years?

Authors:  Barry E Levin; Vanessa H Routh; Ling Kang; Nicole M Sanders; Ambrose A Dunn-Meynell
Journal:  Diabetes       Date:  2004-10       Impact factor: 9.461

5.  Hypoglycemia-associated autonomic failure in insulin-dependent diabetes mellitus. Recent antecedent hypoglycemia reduces autonomic responses to, symptoms of, and defense against subsequent hypoglycemia.

Authors:  S E Dagogo-Jack; S Craft; P E Cryer
Journal:  J Clin Invest       Date:  1993-03       Impact factor: 14.808

6.  Neural substrates of awakening probed with optogenetic control of hypocretin neurons.

Authors:  Antoine R Adamantidis; Feng Zhang; Alexander M Aravanis; Karl Deisseroth; Luis de Lecea
Journal:  Nature       Date:  2007-10-17       Impact factor: 49.962

7.  Evidence against hypothalamic-pituitary-adrenal axis suppression in the antidiabetic action of leptin.

Authors:  Gregory J Morton; Thomas H Meek; Miles E Matsen; Michael W Schwartz
Journal:  J Clin Invest       Date:  2015-11-03       Impact factor: 14.808

8.  Bidirectional electromagnetic control of the hypothalamus regulates feeding and metabolism.

Authors:  Sarah A Stanley; Leah Kelly; Kaamashri N Latcha; Sarah F Schmidt; Xiaofei Yu; Alexander R Nectow; Jeremy Sauer; Jonathan P Dyke; Jonathan S Dordick; Jeffrey M Friedman
Journal:  Nature       Date:  2016-03-23       Impact factor: 49.962

9.  A parabrachial-hypothalamic cholecystokinin neurocircuit controls counterregulatory responses to hypoglycemia.

Authors:  Alastair S Garfield; Bhavik P Shah; Joseph C Madara; Luke K Burke; Christa M Patterson; Jonathan Flak; Rachael L Neve; Mark L Evans; Bradford B Lowell; Martin G Myers; Lora K Heisler
Journal:  Cell Metab       Date:  2014-12-02       Impact factor: 27.287

10.  Hypothalamic Ventromedial Lin28a Enhances Glucose Metabolism in Diet-Induced Obesity.

Authors:  Jung Dae Kim; Chitoku Toda; Cristina M Ramírez; Carlos Fernández-Hernando; Sabrina Diano
Journal:  Diabetes       Date:  2017-05-26       Impact factor: 9.461

View more
  18 in total

Review 1.  Central Nervous System Control of Glucose Homeostasis: A Therapeutic Target for Type 2 Diabetes?

Authors:  Zaman Mirzadeh; Chelsea L Faber; Michael W Schwartz
Journal:  Annu Rev Pharmacol Toxicol       Date:  2022-01-06       Impact factor: 13.820

2.  SOCS3 Ablation in Leptin Receptor-Expressing Cells Causes Autonomic and Cardiac Dysfunctions in Middle-Aged Mice despite Improving Energy and Glucose Metabolism.

Authors:  João A B Pedroso; Ivson B da Silva; Thais T Zampieri; Leonardo T Totola; Thiago S Moreira; Ana P T Taniguti; Gabriela P Diniz; Maria Luiza M Barreto-Chaves; Jose Donato
Journal:  Int J Mol Sci       Date:  2022-06-10       Impact factor: 6.208

3.  The G209R mutant mouse as a model for human PCSK1 polyendocrinopathy.

Authors:  Manita Shakya; Surbhi Gahlot; Nicolle K Martin; Anoop Arunagiri; Martin G Martin; Peter Arvan; Malcolm J Low; Iris Lindberg
Journal:  Endocrinology       Date:  2022-03-04       Impact factor: 5.051

Review 4.  Brain control of blood glucose levels: implications for the pathogenesis of type 2 diabetes.

Authors:  Kimberly M Alonge; David A D'Alessio; Michael W Schwartz
Journal:  Diabetologia       Date:  2020-10-12       Impact factor: 10.122

Review 5.  Central nervous system regulation of organismal energy and glucose homeostasis.

Authors:  Martin G Myers; Alison H Affinati; Nicole Richardson; Michael W Schwartz
Journal:  Nat Metab       Date:  2021-06-21

Review 6.  Musings on the wanderer: What's new in our understanding of vago-vagal reflexes? VI. Central vagal circuits that control glucose metabolism.

Authors:  Soledad Pitra; Bret N Smith
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2020-11-18       Impact factor: 4.052

7.  The Role of Mediobasal Hypothalamic PACAP in the Control of Body Weight and Metabolism.

Authors:  Nadejda Bozadjieva-Kramer; Rachel A Ross; David Q Johnson; Henning Fenselau; David L Haggerty; Brady Atwood; Bradford Lowell; Jonathan N Flak
Journal:  Endocrinology       Date:  2021-04-01       Impact factor: 4.736

8.  Cross-species analysis defines the conservation of anatomically segregated VMH neuron populations.

Authors:  Alison H Affinati; Paul V Sabatini; Cadence True; Abigail J Tomlinson; Melissa Kirigiti; Sarah R Lindsley; Chien Li; David P Olson; Paul Kievit; Martin G Myers; Alan C Rupp
Journal:  Elife       Date:  2021-05-21       Impact factor: 8.713

9.  Rap1 in the VMH regulates glucose homeostasis.

Authors:  Kentaro Kaneko; Hsiao-Yun Lin; Yukiko Fu; Pradip K Saha; Ana B De la Puente-Gomez; Yong Xu; Kousaku Ohinata; Peter Chen; Alexei Morozov; Makoto Fukuda
Journal:  JCI Insight       Date:  2021-06-08

10.  Dabigatran activates inflammation resolution by promoting fibrinogen-like protein 2 shedding and RvD5n-3 DPA production.

Authors:  Juan Lei; Yu Zhou; Huakan Zhao; Yu Chen; Guifang Yan; Lei Wu; Yanquan Xu; Jiangang Zhang; Xiao Zhang; Jingchun Wang; Dingshan Li; Yongsheng Li
Journal:  Theranostics       Date:  2021-02-20       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.